From: Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy
HR
95%CI
p-value
bRFS
First Follow-up PSA (<0,7 vs. ≥0,7)
0,19
0,07–0,59
<0,01
LF
0,27
0,08–0,96
0,04
MFS
0,14
0,02–0,86
0,03